Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (38)

2024

  1. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

  2. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

    Nutrition Journal, Vol. 23, Núm. 1

2023

  1. Examining associations, moderators and mediators between childhood maltreatment, social functioning, and social cognition in psychotic disorders: a systematic review and meta-analysis

    Psychological Medicine, Vol. 53, Núm. 13, pp. 5909-5932

  2. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

  3. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect

    NeuroImage: Clinical, Vol. 35

  2. Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders

    Journal of Clinical Medicine, Vol. 11, Núm. 22

  3. Social Functioning in Individuals Affected by Childhood Maltreatment: Establishing a Research Agenda to Inform Interventions

    Psychotherapy and Psychosomatics, Vol. 91, Núm. 4, pp. 238-251

  4. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

  5. Validity of the Functioning Assessment Short Tests (FAST), in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 3, pp. 157-166

2021

  1. Difficulties in delivery and depressive symptomatology in schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 1, pp. 66-68

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms

    Frontiers in Psychiatry, Vol. 12

  4. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-β positivity

    Cortex, Vol. 121, pp. 117-124

  2. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

  3. Influence of secondary sources in the Brief Negative Symptom Scale

    Schizophrenia Research

2018

  1. Analyses of karyotype by G-banding and high-resolution microarrays in a gender dysphoria population

    Genes and Genomics, Vol. 40, Núm. 5, pp. 465-473

  2. Anti-Basal Ganglia Antibodies and Streptococcal Infection in ADHD

    Journal of Attention Disorders, Vol. 22, Núm. 9, pp. 864-871